MedPath
FDA Approval

ERTAPENEM SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Dr.Reddys Laboratories Inc.,
DUNS: 802315887
Effective Date
April 30, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ertapenem(1 g in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Gland Pharma Limited

Dr.Reddys Laboratories Inc.,

858971074

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ERTAPENEM SODIUM

Product Details

NDC Product Code
43598-901
Application Number
ANDA212040
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
April 8, 2021
Sodium BicarbonateInactive
Code: 8MDF5V39QOClass: IACT
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT
ErtapenemActive
Code: 2T90KE67L0Class: ACTIMQuantity: 1 g in 1 1
© Copyright 2025. All Rights Reserved by MedPath